In this feasibility study, an ultra-low-dose pediatric chest PCCT protocol was optimized to Sn100 kVp, 2 mAs, pitch 1.5, achieving a phantom effective dose of 14 µSv. In clinical use, the median total effective dose was 11.6 µSv, close to the 8.2 µSv median dose of a single chest radiograph.
The protocol was applied in 24 examinations in 20 children, median age 10 years, and every examination provided sufficient confidence to answer the immediate clinical question. Image quality was strongest for focal abnormalities, known-lesion follow-up, congenital diaphragmatic hernia follow-up, and assessment of ILD progression.
The trade-off is task specificity: readers were less confident when using this ultra-low-dose protocol to rule out previously unknown ILD or bronchiectasis. The authors therefore position it as a targeted follow-up tool rather than a replacement for standard-dose chest CT when subtle diffuse lung disease must be excluded.